‘Get it all’ in your first lumpectomy with MarginProbe.
Doctors answer patients' questions about MarginProbe
MarginProbe helps surgeons assess margins in the operating room.
For breast surgeons, there are critical questions with every lumpectomy performed: Did I remove the right amount of tissue? Are the margins clean? Will I be able to tell my patient that we’ve removed all of the cancer? Did I do my job well?
The MarginProbe® System is a new technology to provide surgeons, for the first time, with the ability to perform an intraoperative margin assessment — a diagnostic procedure to better identify whether the tissue excised during the lumpectomy has positive margins. In approximately five minutes, within the operating room, surgeons can now have immediate information about the presence of cancer cells on the margins of the tumor.
Breast surgeons have said that this is the first significant advance in margin assessment in thirty years.
On December 28, 2012, the MarginProbe System received Premarket Approval by the US Food and Drug Administration.
Latest MarginProbe news
January 10, 2017
Dear colleagues, It has been a very busy and exciting year for the Dune Medical Team. It is with enthusiasm that we carry the progress made in 2016 into the… Read more
January 10, 2017
PRESS RELEASE (January 9, 2017 – Paoli, PA) Dune Medical Devices’ intraoperative margin assessment device MarginProbe has surpassed use in 10,000 breast cancer patients. MarginProbe is the first commercial product… Read more
December 7, 2016
Dr Vincent Reid is the Chairman of Surgery and Head of Surgical Oncology Services at Mercy Medical Center in Cedar Rapids Iowa. He also serves as Assistant Professor of Surgery… Read more